12:15-1:15

Lunch

Session 3 – Open
Technologies for Detecting Unsafe Drugs
Room 100

1:15-1:25

Welcome and Introductions

Larry Gostin, Committee Chair

1:25-1:45

The Strengths and Weaknesses of the Detection Technologies Currently Available

Mark Witkowski, Supervisory Chemist, Trace Examination Section, Forensic Chemistry Center, FDA

1:50-2:10

Importance of Reliable Detection Technologies in the Field

Ashifi Gogo, Chief Executive, Sproxil

2:15-2:30

Break

2:30-2:50

Using Analytic Detection Technologies in Singapore

Lim Chin Chin, Forensic Laboratory Director and Forensic Scientist, Singapore Health Science Authority

2:55-3:15

Using Analytic Detection Technologies in Peru

Percy Alberto Ocampo Rujel, former Executive Director, Directorate of Control and Health Surveillance, Peru

3:20-3:40

Case Study on Merck’s Use of Detection Technologies

Anthony Zook, Director of Anti-Counterfeiting, Merck

3:45-4:30

Panel Discussion, The Future of Reliable Detection Technologies in the Field

Patrick Lukulay, Moderator

Session 4 – Closed
Committee Planning



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement